The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1

The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1

Bibliographic Details
Main Authors:	Thompson Craig B, Premkumar Arumugam, Hwang Daniel S, Madesh Muniswamy, Zong Wei-Xing, Choo Andrew Y, Muthumani Karuppiah, Weiner David B
Format:	Article
Language:	English
Published:	BMC 2006-12-01
Series:	Retrovirology

Similar Items

PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
by: Arnold Tan, et al.
Published: (2023-04-01)

Vpr is preferentially targeted by CTL during HIV-1 infection.
by: Altfeld, M, et al.
Published: (2001)

Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr.
by: Eri Takeda, et al.
Published: (2011-01-01)

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins
by: Deshmane Satish L, et al.
Published: (2011-10-01)

Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
by: Jung-Eun Park, et al.
Published: (2024-03-01)

HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
by: Claire Maudet, et al.
Published: (2013-01-01)

Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
by: Jay Lubow, et al.
Published: (2020-07-01)

PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.
by: Angélique N Godet, et al.
Published: (2010-01-01)

Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.
by: Guillaume Jacquot, et al.
Published: (2009-10-01)

The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
by: Michele Tomasicchio, et al.
Published: (2013-01-01)

HIV-1 Vpr – a still "enigmatic multitasker"
by: Carolin Alexandra Guenzel, et al.
Published: (2014-03-01)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
by: Natalya Maluchenko, et al.
Published: (2022-10-01)

HIV-1 Vpr Functions in Primary CD4<sup>+</sup> T Cells
by: Carlos Alberto Vanegas-Torres, et al.
Published: (2024-03-01)

Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.
by: David R Collins, et al.
Published: (2015-07-01)

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
by: Jiayue Ouyang, et al.
Published: (2022-04-01)

The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.
by: Ting Yuan, et al.
Published: (2014-01-01)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
by: Li Zhao, et al.
Published: (2021-06-01)

Direct Vpr-Vpr Interaction in Cells monitored by two Photon Fluorescence Correlation Spectroscopy and Fluorescence Lifetime Imaging
by: Mély Yves, et al.
Published: (2008-09-01)

PARP1: Liaison of Chromatin Remodeling and Transcription
by: Wen Zong, et al.
Published: (2022-08-01)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
by: José Yélamos, et al.
Published: (2020-02-01)

The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.
by: Xiaoyun Wen, et al.
Published: (2012-01-01)

HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
by: Joshua L Andersen, et al.
Published: (2006-12-01)

Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in <it>Saccharomyces cerevisiae</it>
by: Yao Xiao-Jian, et al.
Published: (2004-08-01)

HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
by: Muhammad Atif Zahoor, et al.
Published: (2014-01-01)

The Vpr protein from HIV-1: distinct roles along the viral life cycle
by: Benichou Serge, et al.
Published: (2005-02-01)

HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
by: Nopporn Chutiwitoonchai, et al.
Published: (2016-01-01)

Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor.
by: Kyoji Hagiwara, et al.
Published: (2015-01-01)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
by: Lotte van Beek, et al.
Published: (2021-05-01)

Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages
by: Tomoyuki Murakami, et al.
Published: (2021-11-01)

ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.
by: James W Bruce, et al.
Published: (2021-02-01)

REDD1 Is Essential for Optimal T Cell Proliferation and Survival.
by: Emma L Reuschel, et al.
Published: (2015-01-01)

INFANT VPR-1 VIDEO-REFRACTION AND OCULAR CHARACTERISTICS OF THOSE FAR-FOCUSING AT 75CM
by: Ehrlich, D, et al.
Published: (1995)

PP 3.10 – 00168 Vpr synergizes with vorinostat to prevent HIV-1 latency establishment
by: C. Lewis, et al.
Published: (2022-12-01)

HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.
by: Carlos A Barrero, et al.
Published: (2013-01-01)

Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1.
by: Oliver I Fregoso, et al.
Published: (2013-01-01)

A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma
by: Hui Li, et al.
Published: (2022-08-01)

Visualizing Vpr-induced G2 arrest and apoptosis.
by: Tomoyuki Murakami, et al.
Published: (2014-01-01)

Illuminating the Role of Vpr in HIV Infection of Myeloid Cells
by: Sarah Beth Nodder, et al.
Published: (2019-07-01)

Involvement of Lgl and Mahjong/VprBP in cell competition.
by: Yoichiro Tamori, et al.
Published: (2010-07-01)

The frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with Korean Red Ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on HIV-1 evolution
by: Young Keol Cho, et al.
Published: (2021-01-01)